Menopause Home > Treating Osteoporosis With Mimvey and Off-Label/Pediatric Indications

Using Mimvey for Osteoporosis

Because estrogen helps keep the bones strong, the decrease in estrogen during menopause causes a significant weakening of the bones, often resulting in osteoporosis. By providing estrogen, Mimvey can help prevent these menopause-related bone changes.
However, the drug is not risk-free and should only be used in women who cannot use other, nonhormonal medications for osteoporosis prevention and who are at significant risk for osteoporosis.

Can Children and Teens Take It?

Mimvey is not approved for use in children or teens for any reason.

Is Mimvey Used for Off-Label Reasons?

On occasion, your healthcare provider may recommend this product for something other than the conditions discussed in this article. This is called an "off-label" use. At one point, hormone replacement therapy (such as Mimvey) was used off-label for preventing heart disease and dementia (such as Alzheimer's disease), but these are no longer considered legitimate off-label uses.
Sometimes hormones are used to promote youthfulness. Again, this is not generally accepted as a legitimate off-label use for Mimvey.
Written by/reviewed by:
Last reviewed by: Kristi Monson, PharmD;
Last updated/reviewed:
List of references (click here):
Other Articles in This eMedTV Presentation

Topics & Medications


Related Channels

eMedTV Links
Copyright © 2006-2020 Clinaero, Inc.

eMedTV serves only as an informational resource. This site does not dispense medical advice or advice of any kind. Site users seeking medical advice about their specific situation should consult with their own physician. Click Terms of Use for more information.

This site complies with the HONcode standard for trustworthy health information:
verify here.